This study examines the mutations in BRCA2 and HOXB13 which are some of the best described genes associated with hereditary prostate cancer, emphasizing the rationale of why RFLP could aid in the early diagnosis of patients in regions lacking NGS capabilities. The gene discussed is HOXB13; the disease is prostate carcinoma.